RavenQuest Completes First Cannabis Shipment to Wayland Group
15 4월 2019 - 7:00PM
RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt:
1IT) (the “
Company” or
“
RavenQuest”) a federally licensed producer of
cannabis, is pleased to announce it has completed its first
shipment of bulk cannabis to Wayland Group.
The shipment was made as part of a larger
agreement between RavenQuest and Wayland group, whereby RavenQuest
will supply up to 8,000 kg of bulk cannabis to Wayland Group.
The agreement spans the entirety of calendar 2019.
CEO, George Robinson commented that “it has been
a pleasure dealing with Ben Ward and the entire team at Wayland
Group. We are very excited to complete this first shipment,
which represents the beginning of our agreement as we fulfill our
commitment to supply premium cannabis to our partners at
Wayland.”
“The new license at our Edmonton facility brings
significantly more capacity onstream, dramatically increasing our
revenue potential for 2019. In addition to this agreement, we
have also signed an MOU to supply cannabis to the British Columbia
Liquor Distribution Branch. Between these two distribution
channels and based upon prevailing B2B market prices, we're
confident we can ramp up revenue to north of the budgeted $44.5
million for 2019.” Robinson continued.
For more information, view RavenQuest’s updated
website at www.rqbglobal.com.
Follow RavenQuest on Twitter
@RQBGlobal
About RavenQuest BioMed
Inc.
RavenQuest BioMed Inc. is a diversified publicly
traded cannabis company with divisions focused upon cannabis
production, management services & consulting and specialized
research & development. RavenQuest is a licensed producer
with facilities located in Markham, Ontario and Edmonton,
Alberta.
RavenQuest maintains a research partnership with
McGill University focused upon cultivar (strain) recognition, plant
stabilization and yield maximization of the cannabis plant.
The Company focuses on partnerships with Indigenous
communities.
On Behalf of the Board of Directors
ofRAVENQUEST BIOMED INC.
"George Robinson"Chief Executive Officer
For further information, please contact:
Mathieu McDonald, Corporate Communications
1-877-282-1586
Neither the Canadian Securities Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the Canadian Securities Exchange) accepts
responsibility for the adequacy or accuracy of this press release,
which has been prepared by management.
Cautionary Note Regarding
Forward-Looking Statements
All statements in this press release, other than
statements of historical fact, are "forward-looking information"
with respect to the Company within the meaning of applicable
securities laws, including statements with respect to anticipated
production capacity. The Company provides forward-looking
statements for the purpose of conveying information about current
expectations and plans relating to the future and readers are
cautioned that such statements may not be appropriate for other
purposes. By its nature, this information is subject to
inherent risks and uncertainties that may be general or specific
and which give rise to the possibility that expectations,
forecasts, predictions, projections or conclusions will not prove
to be accurate, that assumptions may not be correct and that
objectives, strategic goals and priorities will not be
achieved. These risks and uncertainties include but are not
limited to those identified and reported in the Company’s public
filings under the Company’s SEDAR profile at www.sedar.com.
Although the Company has attempted to identify important factors
that could cause actual actions, events or results to differ
materially from those described in forward-looking information,
there may be other factors that cause actions, events or results
not to be as anticipated, estimated or intended. There can be no
assurance that such information will prove to be accurate as actual
results and future events could differ materially from those
anticipated in such statements. The Company disclaims any
intention or obligation to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise unless required by law.
Readers are cautioned that budgeted revenue is
based upon prevailing prices for the supply of cannabis products in
business-to-business transactions, and assumes annual production of
11,000 kilograms of cannabis from the Company's Edmonton
facility. A number of factors may cause actual results to
differ materially from budgeted amounts, including changes in the
market price and demand for cannabis products, interruptions in
production and operations at the Company's facility and an evolving
government and regulatory landscape.
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024